Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-619-1 | CAS number: 144-19-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Additional information
Two repeated dose studies are available for 2,2,4-trimethyl-1,3-pentanediol.
In a repeated dose toxicity study, the test material was administered ad libitum at up to 2% in the diet for up to 57 days, the NOAEL was 0.5%. At the highest dose tested, there was a significant reduction in growth rate and body weight gain in females with a corresponding decrease in feed intake. There were no test substance-related deaths and no significant treatment-related effects on clinical signs, hematology, clinical chemistry, gross pathology or histopathology at any dose level tested. There were no significant functional changes in any organ system and target organ effects were limited to changes in absolute and/or relative organ weights. Using feed efficiency data, consumption of 0.5% of TMPD in diet corresponded to an actual average intake of 376 mg/kg/day (367 and 385 mg/kg/day for females and males, respectively).
In another study, the potential for 2,2,4-trimethyl-1,3-pentanediol (TMPD) to cause target organ toxicity following repeated exposure was evaluated based on a key study conducted by Good Laboratory Practices and following regulatory guideline.
A key study, following OECD guideline amd GLP was conducted to determine adverse effects of TMPD for a period of 90 consecutive days on Wistar rats. The test item was administered orally at doses of 30, 120 and 480 mg/kg TMPD in male and female rats. Mortality was observed in two high dose tretaed male rats.In the 480 mg/kg tested group, mild to moderate salivation and mildtonic clonic convulsion were observed post dosing in all animals on multiple days of the study. However, all clinical signs were resolved by the following morning. Correlating parameters showed no treatment related effects in neurobehavioural parameters and functional observation battery parameters. Mean body weight, mean body weight change, and food consumption of treatment groups were comparable with that of the vehicle control group. Changes in haematology and clinical chemistry were considered toxicology insignificant. Increase in liver , adrenal and kidney weights were observed along with histologic changes, however, the changes were considered related to stress and were lower in incidence and in severity (minimal to mild) and not considered relevant to human. Further hepatocellular vacuolation in liver were also noted in control group and therefore the changes were considered as non-adverse. Based on the mortality and convulsions observed at 480 mg/kg b.wt/day treated animals, a NOAEL of 120 mg/kg/d was considered for the study and for DNEL calculations.
Justification for classification or non-classification
There were no treatment-related deaths; no significant functional changes in any organ system; no significant effects on hematology or clinical chemistry parameters; and no significant gross or histopathological organ damage in male and female rats exposed to up to 120 mg/kg/d of the test material given orally for 90 days. 2,2,4-Trimethyl-1,3-pentanediol is not classified for Target Organ Toxicity according to Annex I of Directive 67/548/EEC. Based on the results of a 90 day oarl study in rats, 2,2,4-trimethyl-1,3-pentanediol is not classified for Specific Target Organ Toxicity – Repeated Exposure according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008 or UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.